Telomolecular

Telomolecular was a biotechnology company focused on developing nanotechnologies and genetic therapies aimed at reversing the effects of aging and treating age-related diseases. The company's primary research centered on telomere biology, specifically the use of synthetic telomeres and telomerase-based interventions to extend the replicative lifespan of cells. Their proposed pipeline included treatments for cancer, cardiovascular disease, and neurodegenerative disorders by modulating cellular senescence. Although the company generated significant interest in the early 2000s for its ambitious anti-aging goals, it appears to have ceased active operations without advancing candidates into clinical trials.